Roche: New Test Elevates HIV Diagnostics

Posted: Updated:
Roche says the Elecsys can detect HIV two weeks earlier, because it analyzes antibodies and antigens in the blood. Roche says the Elecsys can detect HIV two weeks earlier, because it analyzes antibodies and antigens in the blood.

Indianapolis was the nerve center for clinical trials that have now led to Roche Diagnostics launching its newest HIV test in the U.S. Roche says the Elecsys HIV combi PT assay is a significant step forward in infectious disease diagnostics; it can detect the virus about two weeks earlier than previous generations and diagnose multiple infectious diseases using a single sample—rather than running multiple tests on different pieces of equipment.

Efficiency is critical when one considers Roche equipment and its assays are responsible for analyzing millions of samples annually inside large reference laboratories. An important feature of the Elecsys assay, or test, is that it’s automated.

“That means less hands-on time required by the medical technologist. It’s our job to streamline their workflow as much as possible by providing efficient testing means,” says Roche Diagnostics Marketing Manager of Infectious Disease Jamie Flanagan. “We’re trying to provide a consolidated approach to the lab; [the Elecsys] has only one touch point on the patient sample. In that patient’s one tube [of blood], it can run all of their infectious disease testing and not have to go back to touch the tube again.”

Unlike earlier generations, the Elecsys can simultaneously test for hepatitis C and syphilis, which are common co-infections. Roche says this reduces the need to obtain multiple samples and use additional analyzers.

“Because HIV, hepatitis c and syphilis are often co-infections in the same patient, it’s important to utilize that one tube to get patient results,” says Flanagan. “It’s a factor in patient satisfaction and patient management from the clinician’s perspective—to have all of the answers from those three assays in one setting and one report.”

The Elecsys, which is a fourth-generation test, can also detect HIV two weeks earlier, because it analyzes antibodies and antigens in the blood; the third-generation assay focuses on only antibodies. The company says another unique factor of the Elecsys is its versatility; the assay can be run in large reference labs or hospital and clinic settings in smaller communities using Roche equipment.

A similar diagnostic tool is helping manage the HIV outbreak in Scott County, caused by the injection drug use of prescription opioids. In the field, the Indiana State Department of Health (ISDH) uses a rapid oral swab for initial detection of the disease, then sends blood samples to the ISDH lab to confirm the diagnosis.

While the state uses a fourth-generation antigen-antibody assay in its lab to detect HIV, the Elecsys—just launched in June of 2017—hasn’t been involved in managing the Scott County outbreak, which surfaced in early 2015. IUPUI Richard M. Fairbanks School of Public Health Associate Professor and Associate Dean of Public Health Practice Dr. Joan Duwve applauds any advances that could expand the public health leaders’ toolbox.

“I recognize the value of scientific achievement, and I’m always excited when science shows us a better way to do things,” says Duwve. “In situations with emerging pathogens, like Ebola or Zika, public health labs actually are first to have access to the latest and greatest diagnostic tests, before they’re even available to commercial labs. Public health labs also work closely with partners at the Centers for Disease Control, other state public health labs or private labs to expand their capacity. With limited public health resources, you have to make sure you’re getting the biggest bang for your buck.”

Roche says its fourth-generation test has been available in other countries for many years and will bring a new level of sensitivity to HIV diagnostics in the U.S.

“The sooner patients are diagnosed in conjunction with the aid of our assay,” says Flanagan, “the sooner they can be treated and receive therapies.” 

Flanagan says a fourth-generation test has been available outside of the U.S. for about 10 years.
Flanagan says Roche’s portfolio of infectious disease assays covers the entire spectrum of volume requirements.
  • Perspectives

    • What the Fit!?

      Good fit in our work, relationships, and, yes, shoes – brings energy and joy into our lives! I recently bought a new pair of shoes. They were very snug, the salesman assured me they would stretch because of the material. I was a little skeptical, but I bought them anyway. This made me think about how shoes also provide some fun clues to assess good “fit” in work and relationships. Even stellar communication and conflict skills won’t make a bad fit feel good.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Jeffersonville to Break Ground on Medical Center

      Leaders from Nicklies Development, Clark County, the city of Jeffersonville and One Southern Indiana will Tuesday break ground on River Ridge Surgical Suites. The $4 million Medical Center will be located on Jeffersonville Commons Drive. 

    • (rendering courtesy of the IEDC)

      Allison Details $400M Expansion Plans

      Allison Transmission Holdins Inc. (NYSE: ALSN) today detailed expansion plans involving more than 300 new jobs through 2020. The company says it will invest more than $400 million over the next few years in projects including a new Vehicle Environmental Test facility and an Innovation Center in Indianapolis. As part of the announcement, Allison today broke ground on the Innovation Center, which is expected to open in 2021. The Innovation Center will feature virtual and physical...

    • (rendering courtesy of the Indiana State Museum and Historic Sites)

      T.C. Steele Historic Site Visitor Center to Open

      The Indiana State Museum and Historic Sites will Saturday celebrate the opening of the new Singing Winds Visitor Center at the T.C. Steele State Historic Site in Nashville. The $2.2 million project broke ground in September 2017 and was funded through public and private donations and grants.

    • Hicks is the director of Ball State's Center for Business and Economic Research.

      BSU Index Updates County Quality of Life Rankings

      A new report from the Center for Business and Economic Research at Ball State University updates the quality of life rankings for every Indiana county. The Community Asset Inventory and Rankings, originally created in 2012, gives a letter grade for each county in seven major categories. Ball State economics professor Michael Hicks says the index gives counties a tool to let them know how they're doing in areas that business and households consider when thinking about relocation.

    • (rendering courtesy of Prince Alexander Architects)

      Demand Fuels Planned Tech Building in Indy

      The business group managing The Union 525 tech hub in downtown Indianapolis is adding to the campus. John Hurley, managing partner of The Union 525, tells Inside INdiana Business plans are moving forward to build a new, $10 million building designed to accommodate the city's growing tech scene. Hurley, who is also the chief executive officer of SmartFile, says The Union 601 will be a six-story, 67,000-square-foot facility that will have a similar open concept feel as its sister...